Cincinnati, OH, United States of America

Matthew D Linnik

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Marion Roussel. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew D Linnik. Retrieved from https://idiyas.com/inventor/matthew-d-linnik-ihfwb3kr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Matthew D. Linnik

Introduction

Matthew D. Linnik is an accomplished inventor based in Cincinnati, OH. He has made significant contributions to the field of neurodegenerative disorder treatments through his innovative work. His expertise and dedication have led to the development of valuable pharmaceutical compounds.

Latest Patents

Matthew D. Linnik holds a patent for "Substituted oxazolidine calpain and/or cathepsin B inhibitors." This invention focuses on oxazolidine inhibitors that target calpain and/or cathepsin B. The compounds developed are particularly useful in treating patients suffering from acute or chronic neurodegenerative disorders.

Career Highlights

Linnik's career has been marked by his role at Hoechst Marion Roussel, where he has contributed to groundbreaking research and development. His work has been instrumental in advancing therapeutic options for patients with neurodegenerative conditions.

Collaborations

Matthew has collaborated with notable colleagues, including Norton P. Peet and Shujaath Mehdi. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Matthew D. Linnik's contributions to the field of neurodegenerative disorder treatments through his patented inventions highlight his role as a significant inventor. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…